MiR-26a functions oppositely in osteogenic differentiation of BMSCs and ADSCs depending on distinct activation and roles of Wnt and BMP signaling pathway

Cell Death and Disease

Volumn 6, Issue , 2015, Pages

  Su, X ^a,b,c   Liao, L ^b   Shuai, Y ^b   Jing, H ^b   Liu, S ^b   Zhou, H ^a   Liu, Y ^c   Jin, Y ^b  

^a XI'AN JIAOTONG UNIVERSITY   (China)

^b FOURTH MILITARY MEDICAL UNIVERSITY   (China)

^c MEDICAL SCHOOL OF XI AN JIAOTONG UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

BONE MORPHOGENETIC PROTEIN; GLYCOGEN SYNTHASE KINASE 3BETA; MICRORNA 26A; SMAD1 PROTEIN; WNT PROTEIN; BONE MORPHOGENETIC PROTEIN RECEPTOR; GLYCOGEN SYNTHASE KINASE 3; GSK3B PROTEIN, MOUSE; MICRORNA; MIRN26 MICRORNA, MOUSE; PROTEIN BINDING; SMAD1 PROTEIN, MOUSE;

ADIPOSE DERIVED STEM CELL; ANIMAL CELL; ANIMAL EXPERIMENT; ARTICLE; BIOINFORMATICS; BONE DEVELOPMENT; BONE MARROW DERIVED MESENCHYMAL STEM CELL; BONE REGENERATION; CELL DIFFERENTIATION; CONTROLLED STUDY; GENE REPRESSION; HEMATOPOIETIC STEM CELL; IN VITRO STUDY; IN VIVO STUDY; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN FUNCTION; PROTEIN PROCESSING; SIGNAL TRANSDUCTION; TISSUE SPECIFICITY; TRANSCRIPTION REGULATION; WNT SIGNALING PATHWAY; ADIPOSE TISSUE; ANIMAL; ANTIBODY SPECIFICITY; BAGG ALBINO MOUSE; BONE MARROW CELL; C57BL MOUSE; CYTOLOGY; GENE EXPRESSION REGULATION; GENETICS; MESENCHYMAL STROMA CELL; METABOLISM; NUDE MOUSE; PRIMARY CELL CULTURE;

ADIPOSE TISSUE; ANIMALS; BONE MARROW CELLS; BONE MORPHOGENETIC PROTEIN RECEPTORS; CELL DIFFERENTIATION; GENE EXPRESSION REGULATION; GLYCOGEN SYNTHASE KINASE 3; GLYCOGEN SYNTHASE KINASE 3 BETA; MESENCHYMAL STROMAL CELLS; MICE; MICE, INBRED BALB C; MICE, INBRED C57BL; MICE, NUDE; MICRORNAS; ORGAN SPECIFICITY; OSTEOGENESIS; PRIMARY CELL CULTURE; PROTEIN BINDING; SIGNAL TRANSDUCTION; SMAD1 PROTEIN; WNT SIGNALING PATHWAY;

EID: 84938770353     PISSN: None     EISSN: 20414889     Source Type: Journal    
DOI: 10.1038/cddis.2015.221     Document Type: Article

References (55)

1. Karsenty G, Kronenberg HM, Settembre C. Genetic control of bone formation. Annu Rev Cell Dev Biol 2009; 25: 629-648.
2. Karsenty G. Transcriptional control of skeletogenesis. Annu Rev Genomics Hum Genet 2008; 9: 183-196.
3. Long F. Building strong bones: molecular regulation of the osteoblast lineage. Nat Rev Mol Cell Biol 2012; 13: 27-38.
4. Stadler BM, Ruohola-Baker H. Small RNAs: keeping stem cells in line. Cell 2008; 132: 563-566.
5. Dirks PB. MicroRNAs and parallel stem cell lives. Cell 2009; 138: 423-424.
6. Clark EA, Kalomoiris S, Nolta JA, Fierro FA. Concise review: MicroRNA function in multipotent mesenchymal stromal cells. Stem Cells 2014; 32: 1074-1082.
7. Li Z, Hassan MQ, Jafferji M, Aqeilan RI, Garzon R, Croce CM et al. Biological functions of miR-29b contribute to positive regulation of osteoblast differentiation. J Biol Chem 2009; 284: 15676-15684.
8. Eskildsen T, Taipaleenmaki H, Stenvang J, Abdallah BM, Ditzel N, Nossent AY et al. MicroRNA-138 regulates osteogenic differentiation of human stromal (mesenchymal) stem cells in vivo. Proc Natl Acad Sci USA 2011; 108: 6139-6144.
9. Oskowitz AZ, Lu J, Penfornis P, Ylostalo J, McBride J, Flemington EK et al. Human multipotent stromal cells from bone marrow and microRNA: regulation of differentiation and leukemia inhibitory factor expression. Proc Natl Acad Sci USA 2008; 105: 18372-18377.
10. Li Y, Fan L, Liu S, Liu W, Zhang H, Zhou T et al. The promotion of bone regeneration through positive regulation of angiogenic-osteogenic coupling using microRNA-26a. Biomaterials 2013; 34: 5048-5058.
11. Luzi E, Marini F, Sala SC, Tognarini I, Galli G, Brandi ML. Osteogenic differentiation of human adipose tissue-derived stem cells is modulated by the miR-26a targeting of the SMAD1 transcription factor. J Bone Miner Res 2008; 23: 287-295.
12. Luzi E, Marini F, Tognarini I, Galli G, Falchetti A, Brandi ML. The regulatory network meninmicroRNA 26a as a possible target for RNA-based therapy of bone diseases. Nucleic Acid Ther 2012; 22: 103-108.
13. Pittenger MF, Mackay AM, Beck SC, Jaiswal RK, Douglas R, Mosca JD et al. Multilineage potential of adult human mesenchymal stem cells. Science 1999; 284: 143-147.
14. Fraser JK, Wulur I, Alfonso Z, Hedrick MH. Fat tissue: an underappreciated source of stem cells for biotechnology. Trends Biotechnol 2006; 24: 150-154.
15. Mizuno H, Tobita M, Uysal AC. Concise review: Adipose-derived stem cells as a novel tool for future regenerative medicine. Stem Cells 2012; 30: 804-810.
16. cDeschaseaux F, Pontikoglou C, Sensebe L. Bone regeneration: the stem/progenitor cells point of view. J Cell Mol Med 2010; 14: 103-115.
17. Zuk PA, Zhu M, Ashjian P, De Ugarte DA, Huang JI, Mizuno H et al. Human adipose tissue is a source of multipotent stem cells. Mol Biol Cell 2002; 13: 4279-4295.
18. Zaidi N, Nixon AJ. Stem cell therapy in bone repair and regeneration. Ann NYAcad Sci 2007; 1117: 62-72.
19. Gomez-Barrena E, Rosset P, Muller I, Giordano R, Bunu C, Layrolle P et al. Bone regeneration: stem cell therapies and clinical studies in orthopaedics and traumatology. J Cell Mol Med 2011; 15: 1266-1286.
20. Wei CC, Lin AB, Hung SC. Mesenchymal stem cells in regenerative medicine for musculoskeletal diseases: bench, bedside, and industry. Cell Transplant 2014; 23: 505-512.
21. Lee RH, Kim B, Choi I, Kim H, Choi HS, Suh K et al. Characterization and expression analysis of mesenchymal stem cells from human bone marrow and adipose tissue. Cell Physiol Biochem 2004; 14: 311-324.
22. Monaco E, Bionaz M, Rodriguez-Zas S, Hurley WL, Wheeler MB. Transcriptomics comparison between porcine adipose and bone marrow mesenchymal stem cells during in vitro osteogenic and adipogenic differentiation. PLoS One 2012; 7: e32481.
23. Park SH, Sim WY, Min BH, Yang SS, Khademhosseini A, Kaplan DL. Chip-based comparison of the osteogenesis of human bone marrow-and adipose tissue-derived mesenchymal stem cells under mechanical stimulation. PLoS One 2012; 7: e46689.
24. Strioga M, Viswanathan S, Darinskas A, Slaby O, Michalek J. Same or not the same? Comparison of adipose tissue-derived versus bone marrow-derived mesenchymal stem and stromal cells. Stem Cells Dev 2012; 21: 2724-2752.
25. Izadpanah R, Trygg C, Patel B, Kriedt C, Dufour J, Gimble JM et al. Biologic properties of mesenchymal stem cells derived from bone marrow and adipose tissue. J Cell Biochem 2006; 99: 1285-1297.
26. Noel D, Caton D, Roche S, Bony C, Lehmann S, Casteilla L et al. Cell specific differences between human adipose-derived and mesenchymal-stromal cells despite similar differentiation potentials. Exp Cell Res 2008; 314: 1575-1584.
27. Bartel DP. MicroRNAs: target recognition and regulatory functions. Cell 2009; 136: 215-233.
28. Coelho MJ, Fernandes MH. Human bone cell cultures in biocompatibility testing. Part II: effect of ascorbic acid, beta-glycerophosphate and dexamethasone on osteoblastic differentiation. Biomaterials 2000; 21: 1095-1102.
29. Icli B, Wara AK, Moslehi J, Sun X, Plovie E, Cahill M et al. MicroRNA-26a regulates pathological and physiological angiogenesis by targeting BMP/SMAD1 signaling. Circ Res 2013; 113: 1231-1241.
30. Mohamed JS, Lopez MA, Boriek AM. Mechanical stretch up-regulates microRNA-26a and induces human airway smooth muscle hypertrophy by suppressing glycogen synthase kinase-3beta. J Biol Chem 2010; 285: 29336-29347.
31. Suh JH, Choi E, Cha MJ, Song BW, Ham O, Lee SY et al. Up-regulation of miR-26a promotes apoptosis of hypoxic rat neonatal cardiomyocytes by repressing GSK-3beta protein expression. Biochem Biophys Res Commun 2012; 423: 404-410.
32. Krause U, Harris S, Green A, Ylostalo J, Zeitouni S, Lee N et al. Pharmaceutical modulation of canonical Wnt signaling in multipotent stromal cells for improved osteoinductive therapy. Proc Natl Acad Sci USA 2010; 107: 4147-4152.
33. Yang X, Ji X, Shi X, Cao X. Smad1 domains interacting with Hoxc-8 induce osteoblast differentiation. J Biol Chem 2000; 275: 1065-1072.
34. Minear S, Leucht P, Miller S, Helms JA. rBMP represses Wnt signaling and influences skeletal progenitor cell fate specification during bone repair. J Bone Miner Res 2010; 25: 1196-1207.
35. Kamiya N, Kobayashi T, Mochida Y, Yu PB, Yamauchi M, Kronenberg HM et al. Wnt inhibitors Dkk1 and Sost are downstream targets of BMP signaling through the type IA receptor (BMPRIA) in osteoblasts. J Bone Miner Res 2010; 25: 200-210.
36. Mbalaviele G, Sheikh S, Stains JP, Salazar VS, Cheng SL, Chen D et al. Beta-catenin and BMP-2 synergize to promote osteoblast differentiation and new bone formation. J Cell Biochem 2005; 94: 403-418.
37. Chen Y, Whetstone HC, Youn A, Nadesan P, Chow EC, Lin AC et al. Beta-catenin signaling pathway is crucial for bone morphogenetic protein 2 to induce new bone formation. J Biol Chem 2007; 282: 526-533.
38. Zhang R, Oyajobi BO, Harris SE, Chen D, Tsao C, Deng HW et al. Wnt/beta-catenin signaling activates bone morphogenetic protein 2 expression in osteoblasts. Bone 2013; 52: 145-156.
39. Winter A, Breit S, Parsch D, Benz K, Steck E, Hauner H et al. Cartilage-like gene expression in differentiated human stem cell spheroids: a comparison of bone marrow-derived and adipose tissue-derived stromal cells. Arthritis Rheum 2003; 48: 418-429.
40. Toupadakis CA, Wong A, Genetos DC, Cheung WK, Borjesson DL, Ferraro GL et al. Comparison of the osteogenic potential of equine mesenchymal stem cells from bone marrow, adipose tissue, umbilical cord blood, and umbilical cord tissue. Am J Vet Res 2010; 71: 1237-1245.
41. Sakaguchi Y, Sekiya I, Yagishita K, Muneta T. Comparison of human stem cells derived from various mesenchymal tissues: superiority of synovium as a cell source. Arthritis Rheum 2005; 52: 2521-2529.
42. Niemeyer P, Fechner K, Milz S, Richter W, Suedkamp NP, Mehlhorn AT et al. Comparison of mesenchymal stem cells from bone marrow and adipose tissue for bone regeneration in a critical size defect of the sheep tibia and the influence of platelet-rich plasma. Biomaterials 2010; 31: 3572-3579.
43. Shafiee A, Seyedjafari E, Soleimani M, Ahmadbeigi N, Dinarvand P, Ghaemi N. A comparison between osteogenic differentiation of human unrestricted somatic stem cells and mesenchymal stem cells from bone marrow and adipose tissue. Biotechnol Lett 2011; 33: 1257-1264.
44. Lagathu C, Christodoulides C, Virtue S, Cawthorn WP, Franzin C, Kimber WA et al. Dact1, a nutritionally regulated preadipocyte gene, controls adipogenesis by coordinating the Wnt/beta-catenin signaling network. Diabetes 2009; 58: 609-619.
45. Salvatori B, Iosue I, Mangiavacchi A, Loddo G, Padula F, Chiaretti S et al. The microRNA-26a target E2F7 sustains cell proliferation and inhibits monocytic differentiation of acute myeloid leukemia cells. Cell Death Dis 2012; 3: e413.
46. Fu X, Jin L, Wang X, Luo A, Hu J, Zheng X et al. MicroRNA-26a targets ten eleven translocation enzymes and is regulated during pancreatic cell differentiation. Proc Natl Acad Sci USA 2013; 110: 17892-17897.
47. Dey BK, Gagan J, Yan Z, Dutta A. miR-26a is required for skeletal muscle differentiation and regeneration in mice. Genes Dev 2012; 26: 2180-2191.
48. Karbiener M, Pisani DF, Frontini A, Oberreiter LM, Lang E, Vegiopoulos A et al. MicroRNA-26 family is required for human adipogenesis and drives characteristics of brown adipocytes. Stem Cells 2014; 32: 1578-1590.
49. Si ML, Zhu S, Wu H, Lu Z, Wu F, Mo YY. miR-21-mediated tumor growth. Oncogene 2007; 26: 2799-2803.
50. Darido C, Georgy SR, Wilanowski T, Dworkin S, Auden A, Zhao Q et al. Targeting of the tumor suppressor GRHL3 by a miR-21-dependent proto-oncogenic network results in PTEN loss and tumorigenesis. Cancer Cell 2011; 20: 635-648.
51. Kim YJ, Hwang SH, Cho HH, Shin KK, Bae YC, Jung JS. MicroRNA 21 regulates the proliferation of human adipose tissue-derived mesenchymal stem cells and high-fat dietinduced obesity alters microRNA 21 expression in white adipose tissues. J Cell Physiol 2012; 227: 183-193.
52. Flynt AS, Li N, Thatcher EJ, Solnica-Krezel L, Patton JG. Zebrafish miR-214 modulates Hedgehog signaling to specify muscle cell fate. Nat Genet 2007; 39: 259-263.
53. Wang X, Guo B, Li Q, Peng J, Yang Z, Wang A et al. miR-214 targets ATF4 to inhibit bone formation. Nat Med 2013; 19: 93-100.
54. Soleimani M, Nadri S. A protocol for isolation and culture of mesenchymal stem cells from mouse bone marrow. Nat Protoc 2009; 4: 102-106.
55. Sugii S, Kida Y, Berggren WT, Evans RM. Feeder-dependent and feeder-independent iPS cell derivation from human and mouse adipose stem cells. Nat Protoc 2011; 6: 346-358.